Glucagon-like peptide-1 receptor agonist exenatide has no acute effect on MRI-measured exocrine pancreatic function in patients with type 2 diabetes: a randomized trial

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)281-288
JournalDiabetes, Obesity and Metabolism
Volume18
Issue number3
DOIs
Publication statusPublished - Mar 2016

Cite this